Cochinchina momordica seed extract induces apoptosis and cell cycle arrest in human gastric cancer cells via PARP and p53 signal pathways

Nutrition and Cancer

Volumn 64, Issue 7, 2012, Pages 1070-1077

  Liu, Hong Rui ^a   Meng, Lin Yi ^b   Lin, Zhi Yan ^a   Shen, Yang ^b   Yu, Yun Qiu ^a   Zhu, Yi Zhun ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 8; CASPASE 9; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; MOMORDICA COCHINCHINENSIS SEED EXTRACT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOMORDICA COCHINCHINENSIS; PLANT SEED; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; SURVIVAL RATE; UPREGULATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; MOMORDICA; PLANT EXTRACTS; POLY(ADP-RIBOSE) POLYMERASES; SEEDS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84867757377     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.712737     Document Type: Article

References (32)

1. Ishida, B K, Turner, C, Chapman, M H, and, McKeon, T A. 2004. Fatty acid and carotenoid composition of gac (Momordica cochinchinensis Spreng) fruit. J Agric Food Chem, 2: 274-279.
2. Kubota, K, Sato, M, Murakami, T, and, Yamagishi, T. 1971. Pharmacological studies on the saponin isolated from the seed of Momordica cochinchinensis Sprenger. Yakugaku Zasshi, 91: 174-179.
3. Bolognesi, A, Barbieri, L, Carnicelli, D, Abbondanza, A, Cenini, P. 1989. Purification and properties of a new ribosome-inactivating protein with RNA glycosidase activity suitable for immunotoxin preparation from the seeds of Momordica cochinchinensis (abstr). Biochim Biophys Acta, 993: 287-292.
4. Murakami, T, Nagasawa, H, Itokawa, H, Tachi, Y, and, Tanaka, K. 1966. The structure of a new triterpene, momordic acids, obtained from momordica cochinchinensis sprenger. Tetrahedron Letters, 42: 5137-5140.
5. Jung Mook, Kang, Nayoung, Kim, Bongcheol, Kim, Joo-Hyon, Kim, Bong-Yong, Lee. 2010. Enhancement of gastric ulcer healing and angiogenesis by Cochinchina momordica seed extract in rats. J Korean Med Sci, 25: 875-881.
6. Sakwiwatkul, K, Li, R L, Song, X M, and, Hu, S H. 2010. Effect of the extract made from Cochinchina momordica seeds on the humoral immune responses of mice to a commercial foot-and-mouth disease vaccine (serotypes O and Asia 1). Microbiol Immunol, 54: 31-37.
7. Xiao, C, Bao, G, and, Hu, S. 2009. Enhancement of immune responses to Newcastle disease vaccine by a supplement of extract of Momordica cochinchinensis (Lour.) Spreng seeds. Poultry Science, 88: 2293-2297.
8. Luo, P, He, Q, He, X, Hu, Y, Lu, W. 2006. Potent antitumor activity of 10-methoxy-9-nitrocamptothecin. Mol Cancer Ther, 5: 962-968.
9. Yang, F, Chen, Y, Duan, W, Zhang, C, Zhu, H. 2006. SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor. Int J Cancer, 119: 1184-1193.
10. Cryns, V, and, Yuan, J. 1998. Proteases to die for. Genes and Development, 12: 1551-1570.
11. Sandhu, S K, Yap, T A, and, de Bono, J S. 2010. Poly (ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective. Eur J Cancer, 46: 9-20.
12. Fiorillo, C, Ponziani, V, Giannini, L, Cecchi, C, Celli, A. 2006. Protective effects of the PARP-1 inhibitor PJ34 in hypoxic-reoxygenated cardiomyoblasts. Cell Mol Life Sci, 63: 3061-3071.
13. Smith, M L, and, Kumar, M A. 2010. The two faces of tumor suppressor p53-revisited. Mol Cell Pharmacol, 2: 117-119.
14. Fischer, U, Janicke, R U, and, Schulze-Osthoff, K. 2003. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ, 10: 76-100.
15. Tong, X, Lin, S, Fujii, M, and, Hou, D X. 2004. Echinocystic acid induces apoptosis in HL-60 cells through mitochondria-mediated death pathway. Cancer Lett, 212: 21-32.
16. Burlacu, A. 2003. Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol.Med, 7: 249-257.
17. Nijhawan, L P, Budihardjo, D, Srinivasula, I, Ahmad, S M, Alnemri, M. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489.
18. Penninger, J M, and, Kroemer, G. 1996. Molecular and cellular mechanisms of T lymphocyte apoptosis. Adv Immunol, 68: 51-144.
19. Kabra, N H, Cado, D, and, Winoto, A. 1999. A tailless Fas-FADD death-effector domain chimera is sufficient to execute fas function in T Cells but not B cells of MRL-lpr/lpr mice. J Immunol, 162: 2766-2774.
20. Zhu, N, Ware, C F, and, Lai, M M. 2001. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology, 283: 178-187.
21. Tourneur, L, Buzyn, A, and, Chiocchia, G. 2005. FADD adaptor in cancer. Med Immunol, 4 (1)
22. Kischkel, F C, Hellbardt, S, Behrmann, I, Germer, M, Pawlita, M. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Embo J, 14: 5579-5588.
23. Mathieu, J, Flexor, M, Lanotte, M, and, Besancon, F. 2008. A PARP-1/JNK1 cascade participates in the synergistic apoptotic effect of TNFalpha and all-trans retinoic acid in APL cells. Oncogene, 27: 3361-3370.
24. Heeres, J T, and, Hergenrother, P J. 2007. Poly(ADP-ribose) makes a date with death. Curr Opin Chem Biol, 11: 644-653.
25. Zerfaoui, M, Suzuki, Y, Naura, A S, Hans, C P, Nichols, C. 2008. Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: differential requirement for PARP-1 expression and interaction. Cell Signal, 20: 186-194.
26. Harris, S L, and, Levine, A J. 2005. The p53 pathway: positive and negative feedback loops. Oncogene, 24: 2899-2908.
27. Yamaguchi, H, Bhalla, K, and, Wang, H G. 2003. Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria. Cancer Research, 63: 1483-1489.
28. Lane, D P. 1992. guardian of the genome. Nature, 358 (6381): 15-16. p53
29. Fujita, K, Kimura, M, Kondo, N, Sakakbara, A, Sano, D. 2008. Anti-tumor effects of telomelysin for head and neck squamous cell carcinoma. Oncology Reports, 20: 1363-1368.
30. Schluep, T, Gunawan, P, Ma, L, Jensen, G S, Duringer, J. 2009. Polymeric tubulysin-peptide nanoparticles with potent antitumor activity. Clin Cancer Res, 15: 181-189.
31. Heimlich, G, McKinnon, A D, Bernardo, K, Brdiczka, D, Reed, J C. 2004. Bax-induced cytochrome c release from mitochondria depend sonalpha-helices-5 and-6. Biochem J, 378: 247-255.
32. Hoffman, W H, Biade, S, Zilfou, J T, Chen, J, and, Murphy, M. 2002. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem, 277: 3247-3257.